Antimicrobial Effectiveness in Eye Drops: Limited Sterility versus Reduction in Microbial Count

References

1. 1.↵
   World Health Organization. Ophthalmic preparations. In The International Pharmacopoeia, 9th Edition, WHO: Geneva, 2019, Online Version http://apps.who.int/phint/en/p/about (accessed May 11, 2019)
2. 2.↵
   1. Van Santvliet L.,
   2. Ludwig A.

   Determinants of Eye Drop Size. Surv. Ophthalmol. 2004, 49 (2), 197–213.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Titcomb L.

   Are Quality Standards Being Reduced as Eye Drops Are Classed as Devices. Pharm. J. 2010, 284, 633–638.

   OpenUrl
4. 4.↵
   1. Gupta N. V.,
   2. Reddy G. V.

   A Comparative Study of Quality Control Tests for Eye Preparations as per IP, BP and USP. Int. J. Drug Dev. Res. 2015, 7, 0975–9344.
5. 5.↵
   1. Uddin S.,
   2. Al Mamun A.,
   3. Kabir T.,
   4. Setu J. R.,
   5. Zaman S.,
   6. Begum Y.,
   7. Amran S.

   Tests for Ophthalmic Pharmaceuticals: Pharmacopoeial Standards and Specifications. J. Adv. Med. Pharm. Sci. 2017, 14 1–17.

   OpenUrl
6. 6.↵
   British National Formulary, BMJ Group and RPS Publishing: London, 2010; p 59.
7. 7.↵
   1. Sangeetha J.,
   2. Prasanth D. A.

   Bacterial Contamination of In-Use Ocular Medications. IOSR J. Pharm. Biol. Sci. 2017, 12, 96–100.

   OpenUrl
8. 8.↵
   1. Virani S.,
   2. Rewri P.,
   3. Vyas A.

   Microbiological Safety of Using Eye Drops after One Month: Contamination Is a Rule or Mere Regulation? Delhi J. Ophthalmol. 2016, 26 (3), 176–179.

   OpenUrl
9. 9.↵
   Efficacy of Antimicrobial Preservatives. In European Pharmacopoeia (Ph.Eur.), 8th Edition, Council of Europe, Strasbourg, France, 2013; 5.1.3, pp 557–558.

   OpenUrl
10. 10.↵
    U.S. Pharmacopeial Convention, Antimicrobial Effectiveness Testing. In USP 40, USP: Rockville, MD, 2017; 51, pp 111–114.

    OpenUrl
11. 11.↵
    International Organization for Standardization, Ophthalmic optics—Contact lens care products—Antimicrobial preservative efficacy testing and guidance on determining discard date. (ISO 14730: 2014E). ISO: Geneva, 2014.
12. 12.↵
    1. Aulton M. E.

    1. Hodges N.

    Pharmaceutical Pre-formulation: The Physicochemical Properties of Drug Substances. In Pharmaceutics—The Science of Dosage Form Design, 2nd Edition; Aulton M. E., Ed.; Churchill Livingstone: Edinburgh, 2012; pp 623–642.
13. 13.↵
    1. Moser C. L.,
    2. Meyer B. K.

    Comparison of Compendial Antimicrobial Effectiveness Tests: A Review. AAPS Pharm. Sci. Tech. 2011, 12 (1), 222–226.

    OpenUrl
14. 14.↵
    1. Sutton S.,
    2. Porter D.

    Development of the Antimicrobial Effectiveness Test as USP Chapter <51>. PDA J. Pharm. Sci. Technol. 2002, 56 (6), 300–311.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    International Organization for Standardization, Sterilization of health care products—Vocabulary. (ISO/technical standards 11139). ISO: Geneva, 2018.
16. 16.↵
    1. Jayal A. B.,
    2. Johns B. E.,
    3. Purdy K. J.,
    4. Maddocks S. E.

    Draft Genome Sequence of Pseudomonas aeruginosa ATCC 9027 Originally Isolated from an Outer Ear Infection. Am. Soc. Microbiol. 2017, 5, e01397–17.

    OpenUrl
17. 17.↵
    1. Teweldemedhin M.,
    2. Gebreyesus H.,
    3. Atsbaha A. H.,
    4. Asgedom S. W.,
    5. Saravanan M.

    Bacterial Profile of Ocular Infections: A Systematic Review. BMC Ophthalmol. 2017, 17 (1).
18. 18.↵
    1. Spencer W. H.

    Pseudomonas aeruginosa Infections of the Eye. Calif. Med. 1953, 79, 438–443.

    OpenUrlPubMed
19. 19.↵
    1. Hemavathi P. S.,
    2. Sarmah P.,
    3. Shenoy P.

    Profile of Microbial Isolates in Ophthalmic Infections and Antibiotic Susceptibility of the Bacterial Isolates: A Study in an Eye Care Hospital, Bangalore. J. Clin. Diagn. Res. 2014, 8, 23–25.

    OpenUrl
20. 20.↵
    1. Abu Shaqra Q. M.,
    2. Al-Groom R. M.

    Microbiological Quality of Hair and Skin Care Cosmetics Manufactured in Jordan. Int. Biodeterior. Biodegradation 2012, 69, 69–72.

    OpenUrl
21. 21.↵
    1. Sutton S.

    The Antimicrobial Efficacy Test, GMP and Investigations. Microbiology 2013, 16, 40–48.

    OpenUrl
22. 22.↵
    1. Baudouin C.,
    2. Labbé A.,
    3. Liang H.,
    4. Pauly A.,
    5. Brignole-Baudouin F.

    Preservatives in Eyedrops: The Good, the Bad and the Ugly. Prog. Retin. Eye Res. 2010, 29 (4), 312–334.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Pellinen P.,
    2. Huhtala A.,
    3. Tolonen A.,
    4. Lokkila J.,
    5. Mäenpää J.,
    6. Uusitalo H.

    The Cytotoxic Effects of Preserved and Preservative-Free Prostaglandin Analogs on Human Corneal and Conjunctival Epithelium in Vitro and the Distribution of Benzalkonium Chloride Homologs in Ocular Surface Tissues in Vivo. Curr. Eye Res. 2012, 37 (2), 145–154.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Steven D. W.,
    2. Alaghband P.,
    3. Lim K. S.

    Preservatives in Glaucoma Medication. Br. J. Ophthalmol. 2018, 102 (11), 1497–1503.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Kawa J. E.,
    2. Higginbotham E. J.,
    3. Chang I. L.,
    4. Yue B. Y.

    Effects of Antiglaucoma Medications on Bovine Trabecular Meshwork Cells in Vitro. Exp. Eye Res. 1993, 57 (5), 557–565.

    OpenUrlCrossRefPubMedWeb of Science
26. 26.↵
    Appendix XVI C A367-A369. Efficacy of Antimicrobial Preservation. In British Pharmacopoeia. The Stationery Office: London, 2005.
27. 27.↵
    1. Akinkunmi E. O.

    An Evaluation of the Pharmaceutical Quality and Antimicrobial Effectiveness of Some Frequently Used Eye Drops Products Available for Sale in Nigeria. Ann. Trop. Med. Public Health 2013, 6, 221–226.

    OpenUrl
28. 28.↵
    1. Olorode O. A.,
    2. Ofonime O. M.,
    3. Orowo A. E.

    Evaluation of Antimicrobial Effectiveness of Ophthalmic Drops Sold in Nigeria Pharmacy Stores and Market Places. Med. Res. Chron. 2017, 4, 109–122.

    OpenUrl
29. 29.↵
    1. Tsegaw A.,
    2. Tsegaw A.,
    3. Abula T.,
    4. Assefa Y.

    Bacterial Contamination of Multidose Eye Drops at Ophthalmology Department, University of Gondar, Northwest Ethiopia. Middle East Afr. J. Ophthalmol. 2017, 24 (2), 81–86.

    OpenUrl
30. 30.↵
    1. Feghhi M.,
    2. Mahmoudabadi A. Z.,
    3. Mehdinejad M.

    Evaluation of Fungal and Bacterial Contaminations of Patient-Used Ocular Drops. Med. Mycol. 2008, 46 (1), 17–21.

    OpenUrlPubMed
31. 31.↵
    1. Abu Shaqra Q. M.,
    2. Husari N.

    Preservation Efficiency of Some Commercially Available Antacid Suspensions against Pseudomonas aeruginosa ATCC 9027. Int. Biodeterior. 1987, 23 (1), 47–51.

    OpenUrl
32. 32.↵
    1. Uwaezuoke J. C.,
    2. Nnodim J. K.

    Microbiological Quality of Eye Drops Sold in Owerri. Int. J. Pharm. Med. Biol. Sci. 2014, 3, 98–102.

    OpenUrl
33. 33.↵
    1. Saisyo A.,
    2. Oie S.,
    3. Kimura K.,
    4. Sonoda K. H.,
    5. Furukawa H.

    Microbial Contamination of In-Use Ophthalmic Preparations and Its Prevention. Bull. Yamaguchi Med. Sci. 2016, 63, 17–24.

    OpenUrl
34. 34.↵
    1. Kwong M. S.,
    2. Evans D. J.,
    3. Ni M.,
    4. Cowell B. A.,
    5. Fleiszig S. M.

    Human Tear Fluid Protects against Pseudomonas aeruginosa Keratitis in a Murine Experimental Model. Infect. Immun. 2007, 75 (5), 2325–2332.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Preston M. J.,
    2. Fleiszig S. M. J.,
    3. Zaidi T. S.,
    4. Goldberg J. B.,
    5. Shortridge V. D.,
    6. Vasil M. L.,
    7. Pier G. B.

    Rapid and Sensitive Method for Evaluating Pseudomonas aeruginosa Virulence Factors during Corneal Infections in Mice. Infect. Immun. 1995, 63 (9), 3497–3501.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Abu Shaqra Q. M.,
    2. Al-Momani W.,
    3. Al-Groom R. M.

    Susceptibility of Some Bacterial Contaminants Recovered from Commercial Cosmetics in Jordan to Preservatives and Antibiotics. Trop. J. Pharm. Res. 2014, 13 (2), 255–259.

    OpenUrl
37. 37.↵
    1. Mugoyela V.,
    2. Mwambete K. D.

    Microbial Contamination of Nonsterile Pharmaceuticals in Public Hospital Settings. Ther. Clin. Risk Manag. 2010, 6, 443–448.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Sutton S.

    Accuracy of Plate Counts. J. Val. Tech. 2011, 17, 42–46.

    OpenUrl